Sources

6 Total Sources

FDA, Moderna Align on mRNA Flu Shot for 2 Age Groups Ahead of June 18 Panel

Center100%
BioSpace10h ago
FDA, Moderna Align on mRNA-1010 Flu Shot Ahead of June 18 Advisory Committee
Yahoo Finance10h ago
Moderna Is Up 94% This Year: Is It Outperforming Other Vaccine Stocks Like Pfizer and Novavax?
StockTitan10h ago
Moderna expands leadership for 2027-28 launches | MRNA Stock News
TU News10h ago
Buying pressure lifts Moderna stock higher in today's trading
X10h ago
The Vaccines and Related Biological Products Advisory Committee will meet June 18 to discuss Moderna's seasonal flu vaccine mRNA-1010 after the FDA initially refused to accept the application in February.
blog.maryannedemasi.com10h ago
FDA poised to approve Moderna's flu mRNA vaccine despite earlier rejection